ClinicalTrials.Veeva

Menu

The Role of Angiotensinogen Gene Polymorphism in the Pathogenesis of Non-familial Sick Sinus Syndrome

C

China Medical University

Status

Unknown

Conditions

Sick Sinus Syndrome

Treatments

Other: observation

Study type

Observational

Funder types

Other

Identifiers

NCT01310920
DMR99-IRB-316

Details and patient eligibility

About

Evidence has been documented for the close relationship between the arrhythmia pathogenesis and the gene expression in renin-angiotensin system. However, it remains unclear for involvement of RAS in the pathogenesis of non-familial sick sinus syndrome. The researchers thus investigated the possible relationship between non-familial sick sinus syndrome and the polymorphism and haplotype of the AGT promoter.

Enrollment

400 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • sick sinus syndrome

Exclusion criteria

  • 1.Severe systemic disease.
  • 2.Acute coronary syndrome.
  • 3.bradycardia with reversible cause.

Trial design

400 participants in 2 patient groups

sick sinus syndrome
Treatment:
Other: observation
control

Trial contacts and locations

1

Loading...

Central trial contact

Jan-Yow Chen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems